Polychem Ltd
Incorporated in 1956, Polychem Ltd is
in the business of manufacturing of specialty chemicals and property development[1]
- Market Cap ₹ 90.5 Cr.
- Current Price ₹ 2,263
- High / Low ₹ 3,725 / 1,950
- Stock P/E 16.8
- Book Value ₹ 1,051
- Dividend Yield 1.32 %
- ROCE 22.7 %
- ROE 18.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 17.1%
- Debtor days have improved from 70.1 to 54.8 days.
Cons
- Company has a low return on equity of 12.1% over last 3 years.
- Earnings include an other income of Rs.2.31 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
12.63 | 26.70 | 30.75 | 41.54 | 36.64 | 24.63 | 35.78 | 51.24 | 53.87 | 48.72 | |
12.93 | 26.58 | 30.23 | 35.52 | 32.69 | 23.98 | 35.08 | 45.39 | 45.10 | 42.30 | |
Operating Profit | -0.30 | 0.12 | 0.52 | 6.02 | 3.95 | 0.65 | 0.70 | 5.85 | 8.77 | 6.42 |
OPM % | -2.38% | 0.45% | 1.69% | 14.49% | 10.78% | 2.64% | 1.96% | 11.42% | 16.28% | 13.18% |
1.00 | 0.81 | 0.34 | 0.43 | 1.12 | 1.43 | 0.82 | 5.61 | 1.96 | 2.31 | |
Interest | 0.00 | 0.04 | 0.01 | 0.00 | 0.04 | 0.08 | 0.07 | 0.16 | 0.16 | 0.16 |
Depreciation | 0.23 | 0.30 | 0.29 | 0.32 | 0.70 | 0.73 | 0.68 | 0.77 | 1.02 | 1.00 |
Profit before tax | 0.47 | 0.59 | 0.56 | 6.13 | 4.33 | 1.27 | 0.77 | 10.53 | 9.55 | 7.57 |
Tax % | 27.66% | -32.20% | 7.14% | 0.00% | 16.17% | -1.57% | -12.99% | 8.36% | 14.24% | |
0.34 | 0.79 | 0.53 | 6.12 | 3.63 | 1.29 | 0.87 | 9.65 | 8.19 | 6.14 | |
EPS in Rs | 8.42 | 20.05 | 5.69 | 89.60 | 75.99 | 20.54 | 12.62 | 178.96 | 178.22 | 127.23 |
Dividend Payout % | 29.41% | 12.35% | 0.00% | 2.76% | 16.29% | 0.00% | 23.53% | 11.07% | 16.67% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 30% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 105% |
TTM: | -12% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 46% |
3 Years: | 61% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 12% |
Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
Reserves | 14.84 | 18.18 | 18.28 | 21.86 | 24.73 | 25.12 | 27.50 | 34.49 | 40.80 | 42.08 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 | 1.63 | 0.23 | |
1.20 | 3.05 | 3.78 | 5.35 | 7.24 | 7.72 | 5.45 | 7.89 | 8.38 | 9.90 | |
Total Liabilities | 16.44 | 21.63 | 22.46 | 27.61 | 32.37 | 33.24 | 33.35 | 43.59 | 51.21 | 52.61 |
0.54 | 2.20 | 2.23 | 2.66 | 3.56 | 3.10 | 2.57 | 3.63 | 4.12 | 3.91 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 2.19 | 2.90 | 3.06 | 7.43 | 8.12 | 10.13 | 9.38 | 19.02 | 22.51 | 26.52 |
13.71 | 16.53 | 17.17 | 17.44 | 20.69 | 20.01 | 21.40 | 20.94 | 24.58 | 22.18 | |
Total Assets | 16.44 | 21.63 | 22.46 | 27.61 | 32.37 | 33.24 | 33.35 | 43.59 | 51.21 | 52.61 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
0.00 | 0.02 | 0.28 | 3.64 | 5.88 | 1.36 | -2.20 | 5.28 | 6.37 | |
0.00 | -0.01 | 0.27 | -4.20 | -3.61 | 0.56 | -0.87 | -3.81 | -3.10 | |
0.00 | -0.10 | -0.11 | 0.00 | -0.41 | -0.82 | -0.29 | -0.44 | -1.12 | |
Net Cash Flow | 0.00 | -0.09 | 0.45 | -0.56 | 1.87 | 1.10 | -3.36 | 1.03 | 2.16 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 68.20 | 73.55 | 86.41 | 74.95 | 76.81 | 107.14 | 99.87 | 55.70 | 54.81 |
Inventory Days | 120.45 | 118.31 | 95.57 | 73.00 | 79.36 | 119.71 | 93.97 | 96.05 | 93.01 |
Days Payable | 38.06 | 38.78 | 43.13 | 15.70 | 20.21 | 40.79 | 27.70 | 18.16 | 17.85 |
Cash Conversion Cycle | 150.59 | 153.08 | 138.85 | 132.25 | 135.95 | 186.06 | 166.14 | 133.59 | 129.98 |
Working Capital Days | 259.81 | 80.11 | 75.49 | 79.52 | 62.06 | 92.18 | 126.19 | 87.26 | 87.47 |
ROCE % | 5.00% | 3.72% | 33.88% | 18.75% | 5.30% | 2.94% | 17.60% | 22.67% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 15 Nov
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Newspaper Publication of Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2024
-
Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
13 Nov - Approval of standalone and consolidated financial results.
-
Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
13 Nov - Approval of standalone and consolidated financial results.
-
Board Meeting Intimation for To Consider The Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
5 Nov - Board meeting to approve Q2 financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
a) Polystyren:[2]
Cross Linked Polystyrene is a co-polymer
of Styrene & Di Vinyl Benzene which is used
in investment casting, corrosive and marine paints, pharmaceutical formulations, etc.
b) LMPS:[3]
LMPS is a low molecular weight homopolymer of Styrene. It finds applications in precision casting, printing inks, SMC & DMC compounds, microcellular soles & Hawai chappals, PVC extrusion compounds, etc.
c) Acrylate-C:[4]
It is a copolymer of Styrene & Ethyl Acrylate used in Concrete curing & sealing, waterproofing compounds, metal coating formulations, etc.
d) SBA PC - 30 / 50:[5]
It is an emulsion of an Acrylic Co-polymer
used as an additive for modifying cement
mortar /concrete